Related Experiment Videos

The therapeutic actions of theophylline in preterm ventilated infants

Early Human Development
|October 1, 1985
PubMed

Insights

Oral theophylline significantly improved lung function and reduced ventilator dependence in preterm infants. This treatment hastened weaning from mechanical ventilation, offering a potential therapeutic benefit for vulnerable newborns.

Area of Science:

  • Neonatal medicine
  • Respiratory physiology
  • Pharmacology

Background:

  • Preterm infants often require mechanical ventilation due to underdeveloped lungs.
  • Ventilator dependence poses risks including lung injury and prolonged hospitalization.
  • Optimizing respiratory support is crucial for improving outcomes in preterm neonates.

Purpose of the Study:

  • To evaluate the efficacy of oral theophylline in preterm infants.
  • To assess the impact of theophylline on lung compliance and ventilator weaning.
  • To determine if theophylline reduces the duration of mechanical ventilation.

Main Methods:

  • Double-blind, randomized controlled trial.
  • Inclusion of 40 preterm infants (gestational age 24-33 weeks) requiring ventilation.
  • Administration of oral theophylline and assessment of respiratory parameters.

Main Results:

  • Theophylline significantly improved lung compliance (P < 0.05).
  • Theophylline hastened the weaning process from mechanical ventilation (P < 0.01).
  • Significant improvements observed in key respiratory metrics.

Conclusions:

  • Oral theophylline is effective in improving lung function in ventilated preterm infants.
  • Theophylline facilitates earlier discontinuation of mechanical ventilation.
  • Theophylline represents a promising therapeutic option for managing respiratory distress in preterm neonates.

Related Concept Videos